EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment

Min-Chi Chang, Ping-Feng Wu, Yu-Chien Ho, Wen-Ying Lin, Chia-Ying Wu, Szu-Yu Liu, Chia-Jen Liu, Yi-Tsung Lin

Journal of Infection and Public Health · 2024

DOI: 10.1016/j.jiph.2024.05.048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2024. Verfasst von Min-Chi Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Adenosine Monophosphate, Alanine, COVID-19 Drug Treatment, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taipei Veterans General Hospital, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine MonophosphateAlanineCOVID-19 Drug TreatmentAntiviral AgentsRenal InsufficiencySARS-CoV-2HospitalizationAcute Kidney InjuryCOVID-19HumansMaleFemaleAgedMiddle AgedTreatment OutcomeAged, 80 and overRetrospective StudiesTaiwanGlomerular Filtration Rate

Stichwörter der Autor:innen

COVID-19Clinical outcomesRemdesivirSevere renal impairment

Substanzen

remdesivirAdenosine MonophosphateAlanineAntiviral Agents

Autor:innen und Institutionen

  • Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. El…
  • Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Ele…

Förderung

  • Taipei Veterans General Hospital
  • National Science and Technology Council

Zitieren

APA

Chang, M. C., Wu, P. F., Ho, Y. C., Lin, W. Y., Wu, C. Y., Liu, S. Y., Liu, C. J., & Lin, Y. T. (2024). Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.05.048

Vancouver

Chang MC, Wu PF, Ho YC, Lin WY, Wu CY, Liu SY, et al. Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment. Journal of Infection and Public Health. 2024. doi:10.1016/j.jiph.2024.05.048

BibTeX
@article{Chang2024,
  author = {Chang, Min-Chi and Wu, Ping-Feng and Ho, Yu-Chien and Lin, Wen-Ying and Wu, Chia-Ying and Liu, Szu-Yu and Liu, Chia-Jen and Lin, Yi-Tsung},
  title = {Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment},
  journal = {Journal of Infection and Public Health},
  year = {2024},
  doi = {10.1016/j.jiph.2024.05.048}
}
Kostenlos starten →